Hostname: page-component-74656f9884-2dmjx Total loading time: 0 Render date: 2026-11-08T14:03:46.642Z Has data issue: false hasContentIssue false

Efficacy of tiafenacil applied preplant alone or mixed with metribuzin for glyphosate-resistant horseweed control in soybean

Published online by Cambridge University Press:  08 June 2021

David B. Westerveld
Affiliation:
Graduate Student, Department of Plant Agriculture, University of Guelph, Ridgetown, ON, Canada
Nader Soltani*
Affiliation:
Adjunct Professor, Department of Plant Agriculture, University of Guelph, Ridgetown, ON, Canada
David C. Hooker
Affiliation:
Associate Professor, Department of Plant Agriculture, University of Guelph, Ridgetown, ON, Canada
Darren E. Robinson
Affiliation:
Professor, Department of Plant Agriculture, University of Guelph, Ridgetown, ON, Canada
Peter H. Sikkema
Affiliation:
Professor, Department of Plant Agriculture, University of Guelph, Ridgetown, ON, Canada
*
Author for correspondence: Nader Soltani, Department of Plant Agriculture, University of Guelph Ridgetown Campus, 120 Main Street East, Ridgetown, ON N0P 2C0, Canada. (Email: soltanin@uoguelph.ca)
Rights & Permissions [Opens in a new window]

Abstract

Tiafenacil is a recently developed protoporphyrinogen IX oxidase (PPO)-inhibiting herbicide from the pyrimidinedione chemical class that is proposed for use as a preplant (PP) burndown in soybean. Glyphosate-resistant (GR) horseweed is a troublesome weed often found in no-till systems that can dramatically reduce soybean yield; control in soybean has been variable. Five field experiments were conducted over 2019 and 2020 in commercial soybean fields with GR horseweed to determine the biologically effective dose (BED) of tiafenacil and tiafenacil + metribuzin and to compare their efficacy to currently accepted industry standard herbicide treatments in identity-preserved (IP, non-GMO), GR, and glyphosate/dicamba-resistant (GDR) soybean systems. There was no soybean injury with treatments evaluated. The calculated doses of tiafenacil for 50%, 80%, and 95% control of GR horseweed control were 21, 147, and >200 g ai ha−1, respectively, at 8 wk after application (WAA). Lower doses were calculated with the addition of metribuzin (400 g ai ha−1) to tiafenacil for 50% and 80% control, with no dose of tiafenacil + metribuzin providing 95% control. Tiafenacil + metribuzin at 25 + 400 and 50 + 400 g ai ha−1 controlled GR horseweed 88% and 93%, respectively, which was similar to the industry standards of saflufenacil + metribuzin (25 + 400 g ai ha−1) and glyphosate/dicamba + saflufenacil (1,200/600 + 25 g ai ha−1) that provided 98% and 100% control, respectively, at 8 WAA. This study presents the potential utility of tiafenacil + metribuzin as a GR horseweed management strategy in soybean.

Information

Type
Research Article
Copyright
© The Author(s), 2021. Published by Cambridge University Press on behalf of the Weed Science Society of America
Figure 0

Table 1. Year, location, application information, soil characteristics, and crop information for five field trials conducted in Ontario, Canada, in 2019 and 2020.

Figure 1

Table 2. Parameter estimates and calculated effective doses of tiafenacil applied preplant for glyphosate-resistant horseweed control, reduction in biomass and plant density, and soybean yield from five trials completed in 2019 and 2020 in Ontario, Canada.

Figure 2

Table 3. Parameter estimates and calculated effective doses of tiafenacil + metribuzin applied preplant for glyphosate-resistant horseweed control, reduction in biomass and plant density, and soybean yield from five trials completed in 2019 and 2020 in Ontario, Canada.

Figure 3

Table 4. Glyphosate-resistant horseweed control 2, 4, and 8 wk after application (WAA), density and dry biomass at 8 WAA, and soybean yield from five field trials conducted in Ontario, Canada in 2019 and 2020.a

Figure 4

Table 5. Glyphosate-resistant horseweed control at 2, 4, and 8 wk after application (WAA), plant density and dry biomass at 8 WAA with metribuzin, tiafenacil and tiafenacil + metribuzin applied preplant from five field trials conducted in Ontario, Canada in 2019 and 2020.a